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Abstract 
Bowel cancer is the fourth most common cancer in England, and with 1:20 people developing 
bowel cancer, it is the second highest cause of cancer deaths. If diagnosed early treatment can 
be more effective and screening programmes can reduce these mortality figures, yet there are 
some people for whom access and uptake of screening programmes is significantly less than 
the rest of the population - namely people with intellectual disabilities. This articles aims to 
describe the process of co-production when working with a group of people with intellectual 
disabilities to explore why they may be reluctant to access bowel cancer screening 
programmes. Bowel cancer, its incidence and prevalence is introduced; the screening process 
described; and the population involved defined. The co-production process is catalogued, 
where clinicians, academics and people with intellectual disabilities worked together to 
explore the challenges of accessing screening programs. The article concludes with 
recommendation to inform practice. 
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Introduction 
 
In the United Kingdom there are 36,000 new cases of colorectal cancer diagnosed each year 
(Cancer Research UK, 2006). It is the fourth  most common cancer and the second most 
common cause of cancer-related death in the United Kingdom (Cancer Research UK, 2011) , 
accounting for approximately 16,000 deaths per year (Wild et. al, 2006; Quarini & Gosney, 
2009). Early detection and screening can improve function and quality of life (McGovern et. 
al, 2004), and is the cornerstone for the improvement of cancer survival outcomes 
(Department of Health, {DH} 2000). Empirical evidence demonstrates that primary screening 
and secondary investigation for bowel cancer in an ‘asymptomatic’ individual, at increased 
risk, is effective in the reduction of colorectal cancer incidence, mortality and increased 
survival from the disease (Wagner, Herdman & Wadhwa, 1991; Fedele, Jones & Niessen, 
1991; Robinson et. al, 1997; James, Campbell & Hudson, 2002).  
 
More than 95% of colorectal cancers develop from benign adenomatous polyps (Borum, 
2001) with a malignant transformation which is reported to take between 10 years (Winawer, 
1999) and up to 35 years, the adenoma-carcinoma sequence (Jackman & Mayo, 1951; Muto, 
Bussey & Morson, 1975; Peipins & Sandler, 1994; Hardy, Meltzer & Jankowski, 2000).  
Therefore, colorectal cancer is an ideal candidate for screening with a patient-friendly and 
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safe examination.  Early diagnosis, before the development of symptoms, may be an effective 
way of reducing mortality.  It is this which a screening programme seeks to address. 
Colorectal Cancer is ideal for population screening since it is common and has a well 
recognised pre-malignant lesion (the adenoma), treatment of which reduces the risk of cancer 
(West et. al, 2007). 
 
The screening process  
As a result of the UK Government’s commitment to reduce cancer deaths in the under 75s by 
at least 20% in 2010 (DH, 1999) the Bowel Cancer Screening Programme in England was 
planned and introduced in 2006.  It aims to achieve its targets through early detection of 
colorectal cancer and their pre-malignant precursor lesions.  Different screening methods 
were proposed, with varying sensitivities and specificities.  The two principle methods chosen 
for the screening process are Faecal Occult Blood testing (FOBt) and colonoscopy.  The FOBt 
depends on the detection of blood lost from early cancers and adenomas in faecal samples. 
Randomised controlled trials have demonstrated that colorectal cancer mortality can be 
reduced by screening using FOBt (Towler et. al, 1998; Anwar, Hall & EIDer, 1998; 
Kronborg, 2003).  After 10 years of follow-up, screening by FOBt every 2 years led to a 
reduction of 18% in colorectal cancer mortality, regardless of sex and age, in individuals aged 
45 – 75 years, with a shift in detection to early stage Dukes’ A cancers (Kronborg et al.,  
1996; Hewitson et al.,  2007).   As most colorectal cancers begin as a polyp, which are benign 
(non-cancerous) growths on the colon’s inner surface (Boolchand et al., 2006), removing 
these polyps interrupts the adenoma-carcinoma sequence and prevents the development of 
cancer (Winawer et al.,1993; Lieberman, 1998). Therefore, those with a positive FOBt are 
offered colonoscopy as the secondary investigation.  Through this process, the entire surface 
of the colon is examined, pre-cancerous changes and asymptomatic colorectal cancers 
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detected and polyps removed (Levin et al., 2008; Parente, Marino & Crosta, 2009). 
Individuals are entered into a polyp surveillance programme, depending on the findings at 
colonoscopy. 
 
Several factors have been identified which influence participation within the screening 
process, including the fear of the results, dealing with faeces, confusion about the instructions 
and fear of the colonic procedure (McCaffery et. al, 2003; O’Sullivan & Orbell, 2004; 
Chapple et. al, 2008).  Additional reasons for non-compliance included lack of interest, the 
absence of bowel related symptoms, embarrassment and worries about the test being 
unpleasant or painful (Vernon, 1997; MORI, 2009). 
 
The screening programme relies on the willingness of individuals to undergo a certain 
screening test, which may be influenced by perceived advantages and drawbacks of screening 
tests and by knowledge and awareness of colorectal cancer, its risk and screening (Vernon, 
1997; Blalock et al., 1990; Keighley et al.,  2004). Social attitudes towards cancer, 
participation in early detection and screening programmes and compliance with treatment and 
coping strategies, are known to be profoundly affected by individual and cultural beliefs 
(Navon, 1999). Individuals invited to take part in the screening programme might consult 
family members, friends and colleagues who have previously undergone the process. The 
consequence of the Bowel Cancer Screening Programme and previous screening processes 
might also trigger psychological responses and lead to compliance or non-compliance in 
screening processes or treatments (McGovern et al., 2004).   
 
A systematic review illustrates that population-based screening programmes, letter-based and 
GP-based programmes are effective in increasing oncologic screening uptake for the general 
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population (Ferroni, et al., 2012); and yet recent figures suggest that people with an 
intellectual disability in the UK are significantly less likely to receive screening (Osborn et 
al.,  2012). The most common underlying causes of death amongst this population is heart and 
circulatory disorders (22%) and cancer (20%) (CIPOLD, 2013). Understanding and 
identifying exactly what the barriers to screening uptake among PwIDs are and what 
measures can be put into place to improve informed decision making regarding participation 
in this effective health screening program, remains fundamentally important. 
 
An intellectual disability perspective 
Emerson et al.,(2011) estimate that there are approximately 1,198,000 people with intellectual 
disabilities, of which 298,000 are children and young people under the age of 17. Yet they 
remain one of the most marginalized groups in contemporary society (DH, 2001), and never 
more so when it comes to having their health needs identified, assessed and ultimately met. 
People with intellectual disabilities often have worse health than other people in the general 
population, yet have great difficulty accessing appropriate healthcare (Jackson & Read, 2008). 
Research and campaign reports recognize that when people with intellectual disabilities  
access the health care system, they are likely to receive different care and treatment than the 
average person who does not have an intellectual disability (Lin, Wu & Lee, 2003; Mencap 
2004; 2007; 2009; 2013), but research around this area remains sparse (Jansen et al 
2004).What is known is that the uptake of bowel cancer screening generally remains low for 
this marginalized population, for a whole host of reasons (Read & Latham, 2009).  
 
Whilst resources alone will never replace education and training around the potential 
complexities when caring for people with intellectual disabilities  and their health needs, 
toolkits have a flexibility of usage (Read et al.,  2011), can reinforce best practice (Read & 
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Rushton, 2013) and  promote informed choice. As part of the process of developing a research 
proposal to develop a toolkit to improve informed decision making for people with 
intellectual disabilities around bowel cancer screening programs, the authors worked in co-
production with a group of people with intellectual disabilities to shape the direction, process 
and content of the proposal. This paper will critically present this co-production process of 
working together to explore this issue.  
 
Co-production as a way of working with others  
Self-determination (according to co-production theorists) relies on opportunities to create 
solutions rather than simply being perceived as part of the problem (Corcoran, 2014). Co-
production refers to the contribution of service users to the provision of services, has 
historical roots in civil rights and social care in the USA, and more latterly in the UK health 
and social care services (Ralpe & Wallace, 2010). Co-production is internationally recognized 
as an empowering approach within statutory and other sectors and is fundamental to person-
centred advocacy. Reflection and feedback from people with intellectual disabilities has 
become an essential part of co-production in advocacy (Corcoran, 2014).  
 
Aims  
 
The aims of this paper are to describe the integral process of working in coproduction with 
people with intellectual disabilities; introduce the outcomes of this in relation to bowel cancer 
screening; and establish principles for good research practice. 
 
Rationale  
The life expectancy of people with intellectual disabilities is steadily increasing (Emerson and 
Hatton 2008), yet despite this evidence poor access to health promotion and cancer screening 
programs prevails (Disability Rights Commission {DRC} 2006). As age is a predisposing 
                                                                             8 | P a g e  
 
factor to the incidence of bowel cancer, with 72% of people diagnosed over 65 (NHS choices 
2014), cancer screening needs to take a higher profile in the care of people with intellectual 
disabilities. Many people with intellectual disabilities will be affected by cancer during their 
life time, either personally or because people they know have had the disease (Hanna et al 
2011), a view echoed in our discussions. Although cancer rates have been found to be slightly 
lower in people with intellectual disabilities than the general population, they are beginning to 
rise (Tuffrey-Wijne et al 2009), yet access to screening programs remains problematic. 
Improving healthcare services for people with intellectual disabilities  is challenging due to a 
lack of information in appropriate formats (Howelson, Clarke 2013), and many people with 
intellectual disabilities  are still heavily reliant on carers to identify and communicate their 
health needs (Felche et al 2008).To ensure equity and parity of treatment, people with 
intellectual disabilities should be supported to access health services, based on the 
fundamental principles advocated in government legislation (DH, 2001), i.e. independence, 
choice, rights and inclusion. Accessible information needs to be clearly written, to ensure 
people can make informed choices, understand their rights and have their say (Dawson 2011). 
Despite this there is consistently lower rates of cancer screening uptake in people with 
intellectual disabilities compared with the general public (DH, 2004). 
Limited empirical research is available to investigate intellectual disability’s healthcare 
professionals’ awareness of cancer screening programmes and their eligibility criteria. Rees 
(2011) found that knowledge appeared limited, with the majority of staff attributing their 
information about cancer screening from the media and their own experience. Rees (2011) 
also acknowledges the lack of evidence to suggest that education and training programmes 
specific to cancer screening is offered to professionals working with people with intellectual 
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disabilities. If this group of people and their carers are not aware of the need for cancer 
screening, the uptake is likely to continue to be poor (DRC, 2006).  
METHODS 
Consent 
This consultation was not formally classified as research, but as participant engagement prior 
to research so that the research questions and processes would be informed by the experiences 
and insights of the participants.  The paper is not aiming to report research; rather it is 
advocating for, and presenting an example of, co-production to inform research.  
People with an intellectual disability were initially approached since they had previously been 
involved in discussions and projects around issues such as loss, death, dying. Individuals had 
worked in groups and as individuals and had sought support from the organisation over a 
period of time in a number of different ways. As a result of their experiences, people sought 
to be involved in project work, and the initiative to become involved in health related topics 
originated from individuals themselves who were looking for ways to explore such issues and 
to express their thoughts in order to make a difference. Process consent (Beaver et al, 1999) is 
a concept that involves constant checking for wanting to be involved before and throughout 
any sensitive meeting, and was used throughout this consultation process. Written consent to 
participate using clear information was arranged at the advocacy organization. 
 
Participants 
All participants were aged 40 plus, were able to consent, and able to communicate verbally 
(although two had communication impairments, they could make their views, needs and 
wants known. All participants except one male lived at home with family members. 
The variety of backgrounds and expertise of the facilitators was helpful in providing 
meaningful support both during and following the consultation meeting. One facilitator had 
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an extensive background in bereavement support; the two clinical facilitators were able to 
clarify terminology, expectations and understanding around issues pertaining to the body and 
the impact of cancer. The advocacy organisation had a range of independent advocates 
available to support any participant after the session as required. 
 
A consultation meeting (10-12.30, followed by lunch) was held with one of the authors, six 
people with intellectual disabilities (four men; two women), an advocate from Reach, Asist, 
(an established advocacy organisation in Stoke on Trent, Staffordshire) and two specialist 
nurses from a local hospital NHS Trust. The advocate had previously met with the 
participants to explain what the meeting was about and to ascertain their informed consent to 
participate, given the potential sensitive nature of the discussion.  Following the consultation, 
a feedback session was organised to which all participants were invited; and a report using 
clear information was written in conjunction with the participants. 
 
Procedure 
The purpose of the meeting was to share ideas about health screening for bowel cancer using 
creative consultation methods. The discussion revolved around the four key areas: 
1. To explore the reasons for poor bowel cancer screening uptake 
2. To clarify people with an intellectual disability’s understanding of health screening 
and its importance 
3. To establish appropriate ways to engage people with an intellectual disability in 
research 
4. To help to discover practical interventions to promote bowel cancer screening. 
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The meeting was facilitated by the first author, and experienced academic, and the third 
author, an experienced advocate.  
 
An anatomical model of a body was used to show participants where the bowels were located 
and how different parts of the body works. To facilitate meaningful engagement, posters were 
also designed and used throughout, where people with intellectual disabilities were 
encouraged to write or draw ideas and comments on post-it notes which were then displayed 
on the posters. This process promoted ownership of the ideas to the group participants 
themselves and also helped the participants to think about why health screening is important 
and to share their personal experiences and questions (see Figure 1).  
 
Insert Figure 1. How we worked together  
 
Outcomes 
Whilst the primary aim of the co-production meeting was to learn from people with 
intellectual disabilities about accessing bowel cancers screening, reciprocal learning was 
evident. People with intellectual disabilities had a thirst for knowledge around cancer 
generally and bowel cancer specifically, and whilst they had a number of professionals to 
address their health questions, they fully maximized this opportunity. Seeing the manikin of 
the body fascinated members of the group, as no-one had seen a three dimensional model of 
the body presented in this way before. They leaned forwards to access a better view of the 
manikin, and asked pertinent questions regarding the what, where and how of the main body 
parts. The clinicians had taken along a bowel cancer screening kit, and this was explored and 
passed around the group to enable members to fully appreciate what we were talking about.  
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Some members talked about family members who had experienced cancer, some of whom 
had survived, some who had died. There were many questions around who gets cancer and 
why, and members asserted that clear information was important for everyone, not just people 
with intellectual disabilities, as one person commented ‘ ...cancer happens to everyone, all 
classes, all races…’. The focus of the discussion quickly moved on to what gets in the way of 
screening and what helps.  
 
What gets in the way 
Obstacles included the lack of support as talking about bowel cancer can be sensitive for 
anyone, regardless of the presence of an intellectual disability or not. Group participants said 
that some of the words used in the testing kit and associated information was too scientific. 
They felt that some people may focus on the words and what they meant, and not pay 
attention to the process itself and its importance. The lack of opportunities to talk about bowel 
cancer was raised, and for some participants this was their first opportunity to talk about it. 
One person said they needed more awareness raising amongst people with intellectual 
disabilities and training for staff, so that everyone understood it potential importance. 
 
What would help 
Primarily, participants talked about the need for a variety of accessible information including 
a film to demonstrate the screening process; information accompanied by pictures; and 
accessible (with clear information and pictures) posters in prominent places (such as toilets; 
Day Services; Churches; GP surgeries) to raise awareness. They recognized the importance of 
the media (e.g. TV and radio) in raising issues in soap operas and documentaries, and 
providing a focal point to prompt discussion and debate around this sensitive topic area. In 
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summary, the three key areas raised were clear information; awareness; and support (see 
Figure 2).     
 
Insert Figure 2. What would help 
 
Discussion 
Exploring sensitive topics around health care with people with intellectual disabilities is often 
difficult, since one never knows exactly what issues might be raised by participants, and what 
their understanding and previous experiences may have been. This is exactly the same for the 
rest of the population, as health promoters, palliative care professionals and educators talk 
with the general public, they can never be fully prepared and anticipate exactly what is 
brought up around these areas. In this small group (N=6) three of the participants (50%) 
talked openly about personal experiences of cancer and all (N =6) could relate to health issues 
and the challenges of accessing healthcare. As is often the case, the process of engagement is 
indicative to any meaningful outcomes, and the meeting was held in a private, comfortable, 
accessible environment that was familiar to all participants. Hospitality remains important, 
and drinks and snacks were available throughout, such principles are important features of 
any research.  
 
Empowerment was important, and having the support of a familiar advocate using processes 
that were familiar to the participants helped to ensure that everyone felt comfortable with 
speaking out and speaking up. We all used individual traffic light coloured cards so that 
everyone could slow down the discussions, or interrupt the flow, or indicate that they wanted 
to speak. Using these, plus of flip charts paper, post it notes and brightly coloured pens helped 
everyone to focus, and all of the participants were used to working in this way. 
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Seeing, touching and feeling the screening tools and the manikin maximized engagement with 
the group participants, and health educators are aware of the impact that visual stimuli can 
have on drawing people into a particular topic for discussion. For the participants of this 
consultation group, the visual prompts were really important, since they opened up new 
learning opportunities never before experienced.  
This was a sensitive topic to explore, but it was an issue of particular concern for the six 
participants, some of whom had direct personal concerns with family members around cancer. 
There are few people with intellectual disabilities who successfully access bowel cancer 
screening programmes, and by working in co-production with members of this population 
who we particularly wanted to include, helped the research team to better understand effective 
ways of making the process more accessible and the inherent information more meaningful. If 
we see the people we are concerned about as being central to the solutions to these challenges, 
we are more likely to be able to address these challenges more effectively. Working in this 
way also helped to identify principles of good research practice when working with people 
with intellectual disabilities (see Table 1.), with the objective of submitting a research 
proposal around bowel cancer screening.  
 
Table1. Principles for good research practice 
• Co-production is the essence of developing good processes and can be the the focus of 
research (holistic, equality of skills, working together for mutual benefits) 
• Engage with people who matter 
• Clear, timely, appropriate information and communication is crucial to engagement  
• Face to face discussions promote reciprocal learning 
• Support remains crucial throughout  
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• Understanding your own health is important for everyone 
• Planning is important: venue, environment, comfortable, safe, familiar 
 
Whilst these principles will help to inform good research practice around marginalized groups 
generally, the need for an empirically tested, evidence base around the use of co-production, 
in particular involving people with an intellectual disability, remains important. The poor 
uptake of bowel cancer screening for this population remains problematic, but working 
alongside people with intellectual disabilities may help researchers to articulate their concerns 
more strongly and inform future research proposals in a meaningful way.  
 
Conclusion  
On reflection, this consultation group discussion was not only informative, educative and 
helped in shaping up and informing the development of a research proposal around a very 
sensitive topic area, it was also hugely enjoyable. Working in co-production proved mutually 
beneficial, as local clinicians also learned how to communicate better with a relatively 
unfamiliar population-people with ID. Bringing people with intellectual disabilities, clinical 
partners, advocates and researchers together in this way helps to overtly promote 
understanding and strengthen potential research proposals, ensuring that research remains 
firmly grounded in the reality of practice.  
 
People with an ID have valuable contributions to make across the whole research continuum, 
and working in co-production is a constructive method of engagement that values all parties 
and the contributions that everyone makes, particularly in the palliative care context. The 
conclusion culminated in three recommendations: 
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1. Clear information about screening for bowel cancer, using clear words and pictures, 
films and audio information, is fundamentally important for people with an intellectual 
disability. 
 
2. More opportunities to find out about health screening, at college, the library and 
through educational opportunities should be available to people with an intellectual 
disability. 
 
3. Support should be accessible and available, e.g. hospital staff who could explain 
processes and tests; support from Macmillan Nurses if appropriate. 
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Figures & Tables 
Insert Figure 1. How we worked together  
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Figure 2. What would help 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table1 . Principles for good research practice 
• Co-production is the essence of developing good processes and can be the the focus of 
research (holistic, equality of skills, working together for mutual benefits) 
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• Engage with people who matter 
• Clear, timely, appropriate information and communication is crucial to engagement  
• Face to face discussions promote reciprocal learning 
• Support remains crucial throughout  
• Understanding your own health is important for everyone 
• Planning is important: venue, environment, comfortable, safe, familiar 
 
